PlainRecalls
FDA Devices Moderate Class II Terminated

PROLARYN PLUS Injectable Implant 1.0 cc Plus Calcium Hydroxlyapatite (CaHA) Injectable Implant, Model No. 8044M0K5. An injectable implant used to treat vocal fold insufficiency.

Reported: December 9, 2015 Initiated: October 26, 2015 #Z-0368-2016

Product Description

PROLARYN PLUS Injectable Implant 1.0 cc Plus Calcium Hydroxlyapatite (CaHA) Injectable Implant, Model No. 8044M0K5. An injectable implant used to treat vocal fold insufficiency.

Reason for Recall

The expiration date encoded in the UDI barcode on the label on the product carton and the peelable patient identification label is incorrect.

Details

Recalling Firm
Merz North America, Inc.
Units Affected
9,439 units
Distribution
Distributed US (nationwide) including the Virgin Islands and South Africa.
Location
Raleigh, NC

Frequently Asked Questions

What product was recalled?
PROLARYN PLUS Injectable Implant 1.0 cc Plus Calcium Hydroxlyapatite (CaHA) Injectable Implant, Model No. 8044M0K5. An injectable implant used to treat vocal fold insufficiency.. Recalled by Merz North America, Inc.. Units affected: 9,439 units.
Why was this product recalled?
The expiration date encoded in the UDI barcode on the label on the product carton and the peelable patient identification label is incorrect.
Which agency issued this recall?
This recall was issued by the FDA Devices on December 9, 2015. Severity: Moderate. Recall number: Z-0368-2016.